tenapanor

FDA Drug Profile

tenapanor is listed in the FDA National Drug Code directory with 3 NDC codes. Available dosage form: tablet, film coated.

Drug details

Generic Name
tenapanor
Sponsor
Patheon Pharmaceuticals Inc.
NDC Codes
3
Dosage Forms
TABLET, FILM COATED
Active Ingredients
TENAPANOR HYDROCHLORIDE, TENAPANOR

Indications and Usage

1 INDICATIONS AND USAGE XPHOZAH is indicated to reduce serum phosphorus in adults with chronic kidney disease (CKD) on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy. XPHOZAH is a sodium hydrogen exchanger 3 (NHE3) inhibitor indicated to reduce serum phosphorus in adults with chronic kidney disease (CKD) on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy ( 1 ).

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.